ARIDIS PHARMACEUTICALS INC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ARDS and buy or sell other stocks, ETFs, and their options commission-free!

About ARDS

Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using human monoclonal antibodies, or mAbs, to treat infections. The company was founded by Eric J. 

CEO
Vu L. Truong
CEOVu L. Truong
Employees
37
Employees37
Headquarters
Los Gatos, California
HeadquartersLos Gatos, California
Founded
2003
Founded2003
Employees
37
Employees37

ARDS Key Statistics

Market cap
8.91K
Market cap8.91K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
7.27K
Average volume7.27K
High today
$0.0023
High today$0.0023
Low today
$0.0002
Low today$0.0002
Open price
$0.0023
Open price$0.0023
Volume
2.00K
Volume2.00K
52 Week high
$0.05
52 Week high$0.05
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

ARIDIS PHARMACEUTICALS INC(ARDS) stock is priced at $0.00, giving the company a market capitalization of 8.91K.

During the trading session on 2025-12-04, ARIDIS PHARMACEUTICALS INC(ARDS) shares reached a daily high of $0.00 and a low of $0.00. At a current price of $0.00, the stock is 0.0% higher than the low and still -91.3% under the high.

Trading volume for ARIDIS PHARMACEUTICALS INC(ARDS) stock has reached 2K, versus its average volume of 7.27K.

Over the past 52 weeks, ARIDIS PHARMACEUTICALS INC(ARDS) stock has traded between a high of $0.05 and a low of $0.00.

Over the past 52 weeks, ARIDIS PHARMACEUTICALS INC(ARDS) stock has traded between a high of $0.05 and a low of $0.00.

People also own

Based on the portfolios of people who own ARDS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.